Abstract-Retinal vasoconstriction and reduced retinal blood flow precede the onset of diabetic retinopathy. The pathophysiological mechanisms that underlie increased retinal arteriolar tone during diabetes remain unclear. Normally, local Ca 2ϩ release events (Ca 2ϩ -sparks), trigger the activation of large-conductance Ca 2ϩ -activated K ϩ (BK)-channels which hyperpolarize and relax vascular smooth muscle cells, thereby causing vasodilatation. In the present study, we examined BK channel function in retinal vascular smooth muscle cells from streptozotocin-induced diabetic rats. The BK channel inhibitor, Penitrem A, constricted nondiabetic retinal arterioles (pressurized to 70mmHg) by 28%. The BK current evoked by caffeine was dramatically reduced in retinal arterioles from diabetic animals even though caffeine-evoked [Ca 2ϩ ] i release was unaffected. Spontaneous BK currents were smaller in diabetic cells, but the amplitude of Ca 2ϩ -sparks was larger. The amplitudes of BK currents elicited by depolarizing voltage steps were similar in control and diabetic arterioles and mRNA expression of the pore-forming BK␣ subunit was unchanged. The Ca 2ϩ -sensitivity of single BK channels from diabetic retinal vascular smooth muscle cells was markedly reduced. The BK␤1 subunit confers Ca 2ϩ -sensitivity to BK channel complexes and both transcript and protein levels for BK␤1 were appreciably lower in diabetic retinal arterioles. The mean open times and the sensitivity of BK channels to tamoxifen were decreased in diabetic cells, consistent with a downregulation of BK␤1 subunits. The potency of blockade by Pen A was lower for BK channels from diabetic animals. Thus, changes in the molecular composition of BK channels could account for retinal hypoperfusion in early diabetes, an idea having wider implications for the pathogenesis of diabetic hypertension. (Circ Res. 2007;100:703-711.)
D
iabetes causes changes to the structure and function of blood vessels in the retina leading to visual impairment and blindness. 1 The cellular and molecular basis of diabetic retinopathy is not wholly understood although large prospective clinical trials have established the importance of hyperglycaemia in precipitating this disease in both type 1 and type 2 diabetic patients. 2, 3 A major pathway through which hyperglycaemia is believed to contribute to retinal microangiopathy is the disruption of retinal blood flow. Patient-based studies have shown that retinal hemodynamic abnormalities occur before the onset of clinical diabetic retinopathy 4 and that the development and progression of diabetic retinopathy correlates with the extent of the blood flow changes observed. [5] [6] [7] [8] In diabetic patients without retinopathy, retinal arteriolar vasoconstriction 9, 10 and decreased total retinal blood flow has been reported. 4, 11 However, as the disease progresses, the arterioles begin to dilate 12 and bulk retinal blood flow increases in proportion to the severity of retinopathy, and thus the degree of retinal ischemia. 11 Presently, the molecular mechanisms underlying retinal vasoconstriction during early diabetes are unknown, yet an improved understanding of the pathophysiology involved could be crucial to the development of better therapies for the treatment of diabetic retinopathy.
A major factor controlling the contractile state of arterioles is the activity of ion channels on the plasma membranes of the vascular smooth muscle cells (VSMCs). 13 Large-conductance Ca 2ϩ -activated K ϩ (BK) channels are known to play a crucial role in the regulation of arterial smooth muscle tone because blockade of these channels using the specific inhibitor iberiotoxin, causes membrane depolarisation and vasoconstriction in pressurized isolated vessels. 14 BK channels are acti-vated by local Ca 2ϩ release events, termed Ca 2ϩ sparks, resulting from opening of ryanodine receptor (RyR) channels in the sarcoplasmic reticulum (SR 15 ). The activation of BK channels results in outward K ϩ current that opposes VSMC contraction by causing membrane hyperpolarisation. This reduces Ca 2ϩ influx by reducing activation of voltagedependent Ca 2ϩ channels. 15 BK channels are composed of ␣-subunits and accessory ␤-subunits. 16 The ␣-subunit forms the K ϩ selective pore, whereas the ␤ subunits influence the kinetics, pharmacology and Ca 2ϩ sensitivity of BK currents. 17, 18 Four members of the BK ␤-subunit family have been identified to date (␤1-␤4) and the ␤1-subunit is expressed predominantly in VSMCs. 19 Targeted deletion of the ␤1-subunit gene reduces the Ca 2ϩ sensitivity of BK channels and the coupling of Ca 2ϩ sparks to BK channel activity in VSMCs from cerebral arteries. 19, 20 The functional significance of the ␤1-subunit of VSMC BK channels is underlined by the observation that knockout mice are hypertensive and display enhanced vascular reactivity to application of vasoconstrictors. 19, 20 In the present study we have examined the effects of streptozotocin (STZ)-induced diabetes on the properties of BK channels in VSMCs of the rat retinal microcirculation. A clear advantage of using STZ-diabetic rats is that it is well documented that retinal arteriolar vasoconstriction and decreased retinal blood flow occur in this animal model following several weeks of diabetes. 21 These animals subsequently exhibit many of the vasodegenerative changes associated with human diabetic retinopathy. 22 We hypothesized that diabetes causes a downregulation of the ␣-and/or ␤1-subunit, thereby reducing the capacity of the BK channels to hyperpolarise retinal VSMCs and resist vasoconstriction. We show that diabetes reduces coupling between Ca 2ϩ release from RyR sensitive Ca 2ϩ stores and BK channel activation. No alteration in the expression of the pore-forming ␣-subunit was evident, but ␤1-subunit expression was reduced at both the mRNA and protein level. Consistent with this, we found that BK channels in retinal VSMCs from STZ-diabetic animals exhibit a diminished sensitivity to Ca 2ϩ and we provide pharmacological evidence supporting the idea that the expression of functional ␣ϩ␤1 subunit complexes is reduced in diabetes. These results suggest that changes in the molecular composition of BK channels in retinal VSMCs during diabetes might contribute to the onset and early progression of diabetic retinopathy.
Materials and Methods
All procedures with animals were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85 to 23, revised 1996) and the United Kingdom Animals (Scientific Procedures) Act, 1986. Full details of the methods and materials used are in the online data supplement available at http://circres.ahajournals.org.
Results

Characteristics of Experimental Animals
Diabetic animals had higher mean plasma glucose levels (27.8Ϯ1.3mmol/L; nϭ41) than nondiabetic animals (7.6Ϯ0.3mmol/L; nϭ37 PϽ0.001). Mean glycosylated hemoglobin values were 5.9Ϯ0.2% and 17.6Ϯ0.8% in the nondiabetic and diabetic groups, respectively (PϽ0.001). Both sets of animals gained weight during the 3-month experimental period, but the increase was greater in nondiabetic than diabetic rats (304Ϯ17g versus 141Ϯ9.7g, respectively; PϽ0.001).
Functional Significance of BK Channels in Retinal VSMCs
We examined the contribution of BK channels to the regulation of retinal arteriolar tone by pressurizing freshly isolated retinal arterioles from nondiabetic animals to 70mmHg and measuring the change in internal diameter induced by 100nmol/L Penitrem A (Pen A), a potent inhibitor of BK channels. 23 Pen A caused a 28% decrease in the diameter of pressurized retinal vessels (Figure 1 ). These results suggest that BK activity plays an important vasodilatory role in retinal blood vessels. solution containing 1mmol/L 9-anthracene carboxylic acid (9AC) to block Ca 2ϩ activated Cl -channels (Cl Ca channels). Application of 10mmol/L caffeine for 5 seconds evoked large, noisy transient outward currents at positive membrane potentials (Figure 2A and 2C ). These currents were fully abolished by addition of 100nmol/L Pen A (Figure 2A; nϭ6) . Figure 2B shows typical caffeine-induced BK currents in retinal VSMCs from nondiabetic and diabetic animals. Figure  2C shows the average peak current density plotted as a function of voltage for the caffeine-induced BK currents. BK currents evoked by Ca 2ϩ release from caffeine-sensitive Ca 2ϩ stores were dramatically reduced in VSMCs from diabetic animals.
Caffeine
The attenuated BK currents in arterioles from diabetic rats could be explained by decreased Ca 2ϩ release from the caffeine-sensitive stores. To test this, global [Ca 2ϩ ] i responses were measured in retinal VSMCs from nondiabetic and diabetic animals using fura 2 based Ca 2ϩ microfluorimetry ( Figure 3A ). No differences in the peak amplitude of [Ca 2ϩ ] i transients evoked by 10mmol/L caffeine were observed. We also compared the size of caffeine-evoked Cl Ca currents at a range of voltages in myocytes from nondiabetic and diabetic arterioles bathed in normal Hanks' solution containing 100nmol/L Pen A to block BK channels. Application of 10mmol/L caffeine evoked currents that reversed close to E Cl (0mV; Figure 3B and 3D). These were completely abolished in low Cl -Hanks' solution containing the Cl -channel inhibitor, 9AC ( Figure 3B ; nϭ6). Isolation of the caffeine-evoked Cl -currents in diabetic arterioles required longer preincubation times with Pen A (Ϸ20 minutes as compared with Ϸ5-minute for nondiabetic vessels). Figure 3C and 3D show representative traces and summary data for the caffeineevoked Cl -currents in nondiabetic and diabetic retinal VSMCs. The mean peak current densities were similar for normal and diabetic cells at all voltages tested. Thus, it appears that the smaller caffeine-induced BK currents in diabetic retinal VSMCs reflect reduced coupling efficiency between Ca 2ϩ release and BK channel activation rather than defective Ca 2ϩ release.
Ca
2؉ Sparks Are Larger, but STOCs Are Smaller in Diabetic Retinal VSMCs
From a physiological perspective it is well established that Ca 2ϩ sparks activate BK channels generating spontaneous transient outward K ϩ currents (STOCs), modulating vascular tone. 15, 24 STOCs were recorded from retinal VSMCs of nondiabetic and diabetic animals at test potentials between Ϫ80mV to ϩ80mV (increased in 40mV increments) using the perforated patch clamp technique. STOCs were evident at membrane potentials positive to Ϫ40mV and were completely abolished in the presence of 100nmol/L Pen A (nϭ6, nondiabetic VSMCs). Individual STOC events were superimposed ( Figure 4A ) precluding an accurate assessment of STOC amplitudes and frequencies, so we calculated the integral of the STOC densities for recordings lasting 5 to 10 minutes. Visual inspection of the original traces suggested that STOC amplitudes and frequencies were greatly reduced in diabetic retinal VSMCs, and integrated current densities were considerably smaller ( Figure 4A ). These data confirm that retinal VSMCs from diabetic animals demonstrate less spontaneous BK current activity than cells from nondiabetic animals.
Using confocal imaging techniques, we have recently described the presence of 2 distinct populations of spontaneous Ca 2ϩ sparks in retinal VSMCs: "basal" sparks that arise from resting fluorescence levels (ie, from F/F o ϭ0.95 to 1.05) and "sparks on oscillations" that overlay global Ca 2ϩ transients. 25 Figure 4B shows representative images of basal Ca 2ϩ sparks, Ca 2ϩ sparks on oscillations and global Ca 2ϩ oscillations in nondiabetic arteriolar myocytes. We considered the possibility that the lower STOC activity in diabetic retinal VSMCs may reflect reduced spontaneous subcellular [Ca 2ϩ ] i signaling in these cells. Figure 4C shows typical images of basal Ca 2ϩ sparks in nondiabetic and diabetic arteriolar myocytes. Below the image panels, the time course of the normalized fluorescence for each event has been plotted and the traces superimposed. It is evident that the peak amplitude of the Ca 2ϩ spark in the diabetic cell is around twice that of the nondiabetic. Quantitative data for basal Ca 2ϩ sparks, Ca 2ϩ sparks on oscillations and global oscillations in nondiabetic and diabetic VSMCs are summarized in supplemental transients, and of STOC and spark activity, suggest decreased coupling between Ca 2ϩ release and BK channel activation in retinal VSMCs after short-term diabetes. This might be explained by a reduced number of functional BK channels in diabetic myocytes. Quantitative RT-PCR, however, failed to reveal any differences in BK␣ transcript expression in nondiabetic and diabetic retinal arterioles ( Figure 5A ). To assess BK channel density, we also compared depolarization dependent whole-cell BK currents (Figure 5Bi and 5Bii ). Vessels were bathed in low Cl -Hanks' solution containing 1mmol/L 9AC and 10 mmol/L 4-aminopyridine (4AP) to block Cl Ca and K v channels, 26 respectively. 10 mmol/L 4AP has no effect on BK channels in retinal arterioles; caffeine-evoked BK currents at ϩ40mV in the absence and presence of 10 mmol/L 4AP were 115Ϯ29.8 and 114Ϯ26pA/pF, respectively (nϭ4; Pϭ0.84; paired t-test). Voltage-activated BK currents in control VSMCs were unaffected by the removal of extracellular Ca 2ϩ , inhibition of voltage-dependent Ca 2ϩ channels with 10 mol/L nifedipine or blockade of RyR receptors with 100 mol/L tetracaine (Figure 5Biii-v) . This demonstrates that BK currents evoked by depolarisation are independent of Ca 2ϩ influx and Ca 2ϩ store release in these cells ie, they appear to be entirely dependent on voltage gating of the BK channels. As such, the peak current density should be proportional to the number of functional BK channels, assuming that the single-channel conductance and the voltage dependence of activation remain constant. Single channel conductance's of BK channels were similar for nondiabetic and diabetic VSMCs (160Ϯ2pS and 160Ϯ4pS, respectively; nϭ21 and 15 patches, PϾ0.05). Figure 5C shows the average peak current density as a function of voltage for the voltageactivated BK currents in retinal VSMCs from nondiabetic and diabetic animals. No differences were observed, suggesting that BK channel density is unaltered in retinal VSMCs during diabetes. Consistent with this, in single channel recordings we found no difference in the number of BK channels per membrane patch in nondiabetic (2.4Ϯ0.2 channels) and diabetic (2.1Ϯ0.2 channels) retinal VSMCs (PϾ0.05, nϭ40 patches).
Another possible explanation for the reduced coupling between Ca 2ϩ release and BK channel activation is a decrease in the sensitivity of the BK channels to activation by Ca 2ϩ .
We examined the Ca 2ϩ -sensitivity of BK channels using inside-out membrane patches from retinal VSMCs (Figure 6 ). The open probability (P o ) at ϩ80mV was determined for a range of Ca 2ϩ concentrations between 0.01 to 100mol/L ( Figure 6A and 6B). The activity of BK channels from both nondiabetic and diabetic animals increased with increasing Ca 2ϩ concentrations, but the P o versus Ca 2ϩ curve was shifted to the right and the Hill slope was reduced for diabetics ( Figure 6B ). No differences in P o 's were observed at Ca 2ϩ concentrations of 0.01 and 0.1mol/L, and this may explain the similarity in voltage-activated, whole cell BK-currents described above. P o versus voltage relations were also determined at a single Ca 2ϩ concentration, 10mol/L ( Figure 6C ). There was a strong rightward shift along the voltage axis (Ͼ100mV) for BK channels from diabetic animals.
␤1 Expression and Function is Lower in Diabetic Retinal VSMCs
The results above suggest that BK channels in diabetic VSMCs have a reduced Ca 2ϩ sensitivity. Because the Ca 2ϩ sensitivity of BK channels is known to be dependent on the presence of ␤1 accessory subunits, 17,18 a downregulation of the ␤1 subunit could explain the changes observed in diabetes. Expression of the BK␤1 subunit in retinal arterioles from nondiabetic and diabetic animals was investigated at the mRNA level. ␤1 transcripts were approximately 60% less abundant in diabetic than in nondiabetic arterioles ( Figure  7A ). We also estimated changes in expression of the ␤1 subunit by immunohistochemistry. A punctuate distribution of BK␤1-associated fluorescence was apparent throughout the VSMC layer of retinal arterioles from nondiabetic animals ( Figure 7B ). Consistent with the RT-PCR analysis, BK␤1 immunostaining decreased dramatically in retinal arterioles of diabetic rats ( Figure 7B ) ie, BK␤1 expression is reduced in retinal VSMC in diabetes. Besides increasing the Ca 2ϩ sensitivity of the BK␣-subunit, the BK␤1-subunit also modifies the kinetics and pharmacological properties of BK channels. 18 The ␤1 subunit increases the stability of BK channel open states. 27 Recently it has been shown that the xenoestrogen, tamoxifen, markedly increases the P o of BK channels but only when they are associated with a ␤1 subunit. 28 Exposure of BK channels from nondiabetic cells to 1mol/L tamoxifen increased the P o by approximately 1.5-fold but had no significant effect on BK channels from diabetic retinal VSMCs ( Figure 7C ). From these data, we conclude that the reduced coupling efficiency between Ca 2ϩ release and BK channel activation in diabetic retinal VSMCs results from reduced Ca 2ϩ sensitivity of the BK channels, reflecting a decrease in the functional expression of the BK␤1 accessory subunit.
It has also previously been reported that BK␣ϩ␤ channels are markedly less sensitive to blockade by iberiotoxin when compared with BK␣ channels alone. 17 To determine whether the BK␤1 subunit might affect the sensitivity of BK channels to Pen A, we compared the effects of this inhibitor on the P o of BK channels from nondiabetic and diabetic retinal VSMCs ( Figure 7D ). Application of 100 nmol/L Pen A to BK channels from nondiabetic cells caused close to 100% block of channel activity. By contrast, the P o of BK channels from diabetic cells was reduced by only 27%. These results are consistent with the possibility that BK␤1 increases the sensitivity of BK channels to Pen A, although further studies using heterologous expression systems are required to confirm this.
Discussion
It has been recognized for the past 25 years that abnormal blood flow to the retina occurs during early diabetes and that this may contribute to the pathogenesis of diabetic retinopathy. 12 Despite this, surprisingly little is known about the precise mechanisms linking chronic hyperglycaemia to retinal arteriolar vasoconstriction and reduced retinal blood flow before the onset of overt retinopathy. In the present study, we have identified a major pathophysiological mechanism that Amplifications were performed in triplicate. Nine nondiabetic and 9 diabetic rats were used in total and RNA was isolated from 15 to 25 retinal arterioles collected from 3 nondiabetic and 3 diabetic animals per replicate. BK␣ transcript expression was normalized to ␤-actin. Bi, Family of whole-cell voltage clamp currents evoked in a nondiabetic retinal VSMC by voltage steps ranging between Ϫ100 mV to ϩ100mV from an initial holding potential of Ϫ80mV in the presence of 9AC (1 mmol/L) and 4AP (10mmol/L). Bii, The voltage-dependent current was abolished by the BK channel inhibitor, Pen A (100nmol/L; % change, -99.3Ϯ1.1%; PϽ0.05; nϭ4), but was unaffected by (Biii) the removal of extracellular Ca 2ϩ (2.5Ϯ8.5%; PϾ0.05; nϭ4), (Biv) the L-type Ca 2ϩ channel inhibitor, nifedipine (10 mol/L; -1.6Ϯ17.2%; PϾ0.05 nϭ5) and (Bv) the RyR antagonist tetracaine (100mol/L; 3.4Ϯ15.2%; PϾ0.05; nϭ5). Responses were constant across the full voltage range. For clarity current records are presented for single steps between Ϫ80 to ϩ80mV. Dashed lines: zero current. C, Average peak current density as a function of voltage for the voltage-activated BK current in nondiabetic (nϭ13) and diabetic (nϭ13) vessels.
may play a specific role in the development of retinal perfusion abnormalities in diabetes. We have obtained molecular and functional data to suggest that during diabetes, the BK␤1 subunit is downregulated in retinal VSMCs, whereas the expression of the pore-forming ␣-subunit remains unaltered. Consistent with this, we observed a marked reduction in the Ca 2ϩ sensitivity of BK channels and an uncoupling of BK channel activation from Ca 2ϩ release in diabetic retinal VSMCs. Of particular note, the decreased expression of the ␤1 subunit drastically reduced the ability of spontaneous Ca 2ϩ sparks to activate BK channel-mediated STOCs. Because STOCs act to hyperpolarise and relax VSMCs, 15, 29 loss of STOC activity could well underlie the observed arteriolar vasoconstriction seen in the development of diabetic retinopathy.
Information is generally lacking regarding the effects of diabetes on vascular BK channel function. Coronary microvessels from diabetic dyslipidemic swine exhibit an uncoupling in the relationship between Ca 2ϩ sparks and STOC activation 30 and whole-cell BK current density is reduced in microvascular smooth muscle cells of mesenteric arteries from Zucker diabetic fatty rats 31 and fructose-fed, insulin resistant rats. 32 The precise mechanisms underlying the changes in vascular BK channel activity were not resolved in these studies, although it is interesting that an alteration in BK␤1 expression was not apparent in Zucker diabetic fatty rats. 31 This discrepancy with the present study could possibly be attributed to the different animal models used and the origins of the microvessels studied. In general terms, however, the findings from the current work do strengthen the view that BK channel function is impaired in VSMCs of the microcirculation during diabetes. Intriguingly, impaired BK channel function may be limited to the microvasculature because the P o of BK channels is increased in thoracic aortic VSMCs of STZ-induced diabetic mice. 33 Hypertension is approximately twice as frequent in patients with diabetes compared with patients without the disease. 34 Furthermore work linked to the United Kingdom Prospective Diabetes Study (UKPDS) showed that the incidence of micro-and macrovascular diabetic complications was strongly associated with elevated blood pressure. 35 Presently the etiology of hypertension in diabetic patients is not fully understood, although loss of the normal vascular relaxation to insulin in both type 1 (insulin-deficiency) and type 2 (insulinresistance) diabetes may contribute. 36 The present study is the first to raise the possibility that there is a selective downregu- Figure 6 . Ca 2ϩ sensitivity of single BK channels is reduced in diabetes. A, Representative single BK channel records in inside-out patches (holding potential ϩ80mV) from nondiabetic and diabetic VSMCs exposed to increasing [Ca 2ϩ ]. B, Summary data of the meanϮSEM P o at the 5 Ca 2ϩ concentrations tested. Nondiabetic, nϭ8 to 11; diabetics, nϭ8 to 11. Curves are fitted with the Hill equation as described in the online data supplement. Fit parameters are as follows: nondiabetic (Kdϭ0.86 mol/L, Hill slope 1.1), diabetic (Kdϭ1.9 mol/L, Hill slope 0.97). C, P o -V relations determined at 10 mol/L Ca 2ϩ . Nondiabetic, nϭ2 to 11; diabetics, nϭ1 to 11. Curves are Boltzmann fits with the following parameters: nondiabetic (V 1/2 ϭ-59.7 mV); diabetic (V 1/2 ϭ57.9 mV). lation of BK␤1 resulting in an impairment of RyR-BK channel signaling which could be an important component in the pathogenesis of hypertension in diabetic patients. However, detailed profiling of BK␤1 expression in a range of vascular tissues during diabetes, particularly in small arteries and arterioles that are central to blood pressure regulation, 37 is required before any firm conclusions can be made. It is likely that a widespread downregulation of BK␤1 in diabetes could be sufficient to induce hypertension because BK␤1 knockout mice are indeed hypertensive. 19, 20 Furthermore, downregulation of BK␤1 has been reported in animal models of both acquired and genetic hypertension. 38, 39 Also, a recent population-based epidemiological study has reported that a gain-of-function polymorphism (E65K) in the BK␤1 subunit, which increased the apparent Ca 2ϩ -and voltage-sensitivity of the pore-forming BK␣ subunit, is associated with a low prevalence of diastolic hypertension in this population. 40 Future work should be directed toward a clearer understanding of the role BK␤1 downregulation in the development of hypertension in diabetic patients as well as elucidating the nature of the signaling mechanisms that regulate BK␤1 expression during diabetes.
Another novel observation in the current study was that Ca 2ϩ spark amplitudes were greater in retinal VSMCs from diabetic animals, even though the frequency and duration of these events were unaltered. It seems unlikely that this represents a compensatory response to the downregulation of BK␤1 and loss of Ca 2ϩ spark/BK channel coupling because the spatiotemporal properties of Ca 2ϩ sparks were unaltered in VSMCs of BK␤1 knockout animals. 19, 20 ] i transients and caffeine-activated Cl Ca currents were similar in retinal VSMCs from nondiabetic and diabetic animals. Diabetic retinal vessels are known to accumulate increased levels of advanced glycation end-products 41 and these adducts are known to accumulate heavily on RyR channels during diabetes. 42 The possible contribution of AGE crosslinking of RyRs to alterations in Ca 2ϩ spark activity in diabetic retinal VSMCs deserves further investigation.
In summary, we have presented data that strongly supports the hypothesis that diabetes downregulates the expression of the BK␤1 subunit and consequently decreases Ca 2ϩ dependent activity of BK channels in retinal VSMCs. Our findings may have important implications with respect to the early pathogenesis of diabetic retinopathy. It is also fascinating to speculate that this mechanism might contribute to the devel- ]) from nondiabetic and diabetic retinal VSMCs. Right, summary data showing the differential effects of tamoxifen on the P o of single BK channels from nondiabetic (nϭ7) and diabetic (nϭ8) vessels. D, Pharmacology of single BK channels from nondiabetic (nϭ5) and diabetic (nϭ9) retinal VSMCs exposed to Pen A. Mean data are expressed as the % inhibition of P o after 5-minute of exposure to 100 nmol/L Pen A. opment of hypertension in diabetic patients, although more extensive studies are needed to fully evaluate this possibility. 
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